Vycor Medical (VYCO) Cash from Financing Activities (2010 - 2026)
Vycor Medical (VYCO) reported Cash from Financing Activities of -$14910.0 for Q1 2026, up 15.72% year-over-year from -$12885.1 in Q1 2025, and little changed on a QoQ basis from -$14874.0 in Q4 2025.
Vycor Medical (VYCO) has 17 years of Cash from Financing Activities data on file, last reported at -$14910.0 in Q1 2026.
- Quarterly Cash from Financing Activities rose 15.72% year-over-year to -$14910.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1968.0 (up 121.25% YoY) and the FY2025 annual result came in at -$812.0, up 89.25% from the prior year.
- Cash from Financing Activities was little changed at -$14910.0 in Q1 2026 per VYCO's latest filing, from -$14874.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $68409.0 in Q1 2022 and bottomed at -$17690.0 in Q1 2025.
- The 5-year median for Cash from Financing Activities is -$8819.0 (2023), against an average of $8401.4.
- The widest annual swing landed in 2022, when Cash from Financing Activities soared 293.33%; it then tumbled 130.31% in 2023.
- Tracing VYCO's Cash from Financing Activities over 5 years: stood at $37497.0 in 2022, then slumped by 130.31% to -$11367.0 in 2023, then declined by 22.06% to -$13874.0 in 2024, then fell by 7.21% to -$14874.0 in 2025, then fell by 0.24% to -$14910.0 in 2026.
- Per Business Quant, the three latest VYCO Cash from Financing Activities figures stand at -$14910.0 (Q1 2026), -$14874.0 (Q4 2025), and $36957.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 | -14,910.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14,910.00 |
| Mar 31, 2026 | -14,910.00 |
| Dec 31, 2025 | -14,874.00 |
| Dec 31, 2025 | -14,874.00 |
| Sep 30, 2025 | 36,957.00 |
| Sep 30, 2025 | 36,957.00 |
| Jun 30, 2025 | -5,205.00 |
| Jun 30, 2025 | -5,205.00 |
| Mar 31, 2025 | -17,690.00 |
| Mar 31, 2025 | -17,690.00 |
| Dec 31, 2024 | -13,874.00 |
| Dec 31, 2024 | -13,874.00 |
| Sep 30, 2024 | 32,898.00 |
| Sep 30, 2024 | 32,898.00 |
| Jun 30, 2024 | -10,595.00 |
| Jun 30, 2024 | -10,595.00 |
| Mar 31, 2024 | -15,983.00 |
| Mar 31, 2024 | -15,983.00 |
| Dec 31, 2023 | -11,367.00 |
| Dec 31, 2023 | -11,367.00 |
| Sep 30, 2023 | 34,536.00 |
| Sep 30, 2023 | 34,536.00 |
| Jun 30, 2023 | -8,819.00 |
| Jun 30, 2023 | -8,819.00 |
| Mar 31, 2023 | -14,139.00 |
| Mar 31, 2023 | -14,139.00 |
| Dec 31, 2022 | 37,497.00 |
| Dec 31, 2022 | 37,497.00 |
| Sep 30, 2022 | 65,600.00 |
| Sep 30, 2022 | 65,600.00 |
| Jun 30, 2022 | -5,617.00 |
| Jun 30, 2022 | -5,617.00 |
| Mar 31, 2022 | 68,409.00 |
| Mar 31, 2022 | 68,409.00 |
| Dec 31, 2021 | -19,395.00 |
| Dec 31, 2021 | -19,395.00 |
| Sep 30, 2021 | 38,727.00 |
| Sep 30, 2021 | 38,727.00 |
| Jun 30, 2021 | -8,517.00 |
| Jun 30, 2021 | -8,517.00 |
| Mar 31, 2021 | 51,130.00 |
| Mar 31, 2021 | 51,130.00 |
| Dec 31, 2020 | -21,082.00 |
| Dec 31, 2020 | -21,082.00 |
| Sep 30, 2020 | 167,862.00 |
| Sep 30, 2020 | 167,862.00 |
| Jun 30, 2020 | 60,919.00 |
| Jun 30, 2020 | 60,919.00 |
| Mar 31, 2020 | 78,853.00 |
| Mar 31, 2020 | 78,853.00 |
| Dec 31, 2019 | -3,026.00 |
| Dec 31, 2019 | -3,026.00 |
| Sep 30, 2019 | 25,490.00 |
| Sep 30, 2019 | 25,490.00 |
| Jun 30, 2019 | -22,075.00 |
| Jun 30, 2019 | -22,075.00 |
| Mar 31, 2019 | 39,702.00 |
| Mar 31, 2019 | 39,702.00 |
| Dec 31, 2018 | -21,052.00 |
| Dec 31, 2018 | -21,052.00 |
| Sep 30, 2018 | 53,786.00 |
| Sep 30, 2018 | 53,786.00 |
| Jun 30, 2018 | 112,521.00 |
| Jun 30, 2018 | 112,521.00 |
| Mar 31, 2018 | 55,166.00 |
| Mar 31, 2018 | 55,166.00 |
| Dec 31, 2017 | 86,682.00 |
| Dec 31, 2017 | 86,682.00 |
| Sep 30, 2017 | -27,303.00 |
| Sep 30, 2017 | -27,303.00 |
| Jun 30, 2017 | -14,350.00 |
| Jun 30, 2017 | -14,350.00 |
| Mar 31, 2017 | 818,822.00 |
| Mar 31, 2017 | 818,822.00 |
| Dec 31, 2016 | 83,176.00 |
| Dec 31, 2016 | 83,176.00 |
| Sep 30, 2016 | 38,009.00 |
| Sep 30, 2016 | 38,009.00 |
| Jun 30, 2016 | 171,340.00 |
| Jun 30, 2016 | 171,340.00 |
| Mar 31, 2016 | -25,815.00 |
| Mar 31, 2016 | -25,815.00 |
| Dec 31, 2015 | -16,391.00 |
| Dec 31, 2015 | -16,391.00 |
| Sep 30, 2015 | -28,629.00 |
| Sep 30, 2015 | -28,629.00 |
| Jun 30, 2015 | -14,952.00 |
| Jun 30, 2015 | -14,952.00 |
| Mar 31, 2015 | -25,328.00 |
| Mar 31, 2015 | -25,328.00 |
| Sep 30, 2014 | -11,835.00 |
| Sep 30, 2014 | -11,835.00 |
| Jun 30, 2014 | 841,542.00 |
| Jun 30, 2014 | 841,542.00 |
| Mar 31, 2014 | 3.85 Mn |
| Mar 31, 2014 | 3.85 Mn |
| Dec 31, 2013 | 171,486.00 |
| Dec 31, 2013 | 171,486.00 |
| Sep 30, 2013 | 198,508.00 |
| Sep 30, 2013 | 198,508.00 |
| Jun 30, 2013 | 378,451.00 |
| Jun 30, 2013 | 378,451.00 |
| Mar 31, 2013 | 340,626.00 |
| Mar 31, 2013 | 340,626.00 |
| Dec 31, 2012 | 126,873.00 |
| Dec 31, 2012 | 126,873.00 |
| Sep 30, 2012 | 493,193.00 |
| Sep 30, 2012 | 493,193.00 |
| Jun 30, 2012 | 113,563.00 |
| Jun 30, 2012 | 113,563.00 |
| Mar 31, 2012 | -5,261.00 |
| Mar 31, 2012 | -5,261.00 |
| Dec 31, 2011 | -41,678.00 |
| Dec 31, 2011 | -41,678.00 |
| Sep 30, 2011 | 658,910.00 |
| Sep 30, 2011 | 658,910.00 |
| Jun 30, 2011 | 2.91 Mn |
| Jun 30, 2011 | 2.91 Mn |
| Mar 31, 2011 | 642,751.00 |
| Mar 31, 2011 | 642,751.00 |
| Dec 31, 2010 | 1.35 Mn |
| Dec 31, 2010 | 1.35 Mn |
| Sep 30, 2010 | 250,000.00 |
| Sep 30, 2010 | 250,000.00 |